Author Question: Which of the following is NOT true of long-term potentiation (LTP)? A) Protein synthesis is ... (Read 199 times)

vicotolentino

  • Hero Member
  • *****
  • Posts: 552
Which of the following is NOT true of long-term potentiation (LTP)?
 
  A) Protein synthesis is required for persistent LTP.
  B) NMDA receptors admit calcium ions when glutamate is present and the membrane is depolarized.
  C) AMPA receptors are inserted into the dendritic membrane during LTP.
  D) Presynaptic nitric oxide acts as a messenger on the postsynaptic membrane.
  E) Glutamate is released from the axon terminal.

Question 2

Inactivation of type II calcium calmodulin kinase would be expected to
 
  A) promote the creation of new NMDA receptors.
  B) promote the formation of new memories.
  C) block the entry of calcium into the postsynaptic cell.
  D) block the formation of long-term potentiation.
  E) facilitate the production of long-term potentiation.



joechoochoy

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

Answer: D
Rationale: Nitric oxide acts as a messenger on the presynaptic membrane.

Answer to Question 2

Answer: D
Rationale: Inactivation of type II calcium calmodulin kinase would be expected to block the formation of long-term potentiation.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

For about 100 years, scientists thought that peptic ulcers were caused by stress, spicy food, and alcohol. Later, researchers added stomach acid to the list of causes and began treating ulcers with antacids. Now it is known that peptic ulcers are predominantly caused by Helicobacter pylori, a spiral-shaped bacterium that normally exist in the stomach.

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

For a complete list of videos, visit our video library